- Home
- CLLS vs CEPV Comparison
CLLS vs CEPV Comparison
Compare CLLS & CEPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.12
Company Overview
Basic Information| Metric | CLLS | CEPV |
|---|---|---|
| Founded | 1999 | 2021 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 324.3M |
| IPO Year | 2014 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CLLS | CEPV |
|---|---|---|
| Price | $1.12 | $10.21 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | ★ 98.3K | 74.9K |
| Earning Date | 11-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.70 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $10.06 |
| 52 Week High | $5.45 | $10.50 |
Technical Indicators
Market Signals| Indicator | CLLS | CEPV |
|---|---|---|
| Relative Strength Index (RSI) | 38.78 | 39.46 |
| Support Level | $0.88 | $10.18 |
| Resistance Level | $2.99 | $10.35 |
| Average True Range (ATR) | 0.10 | 0.01 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 57.67 | 44.44 |
Price Performance
Historical Comparison CLLS
CEPV
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About CEPV Cantor Equity Partners V Inc. Class A Ordinary Shares
Cantor Equity Partners V Inc is a blank check company.